Basic information Safety Supplier Related

Atabecestat

Basic information Safety Supplier Related

Atabecestat Basic information

Product Name:
Atabecestat
Synonyms:
  • Atabecestat
  • JNJ-54861911
  • Atabecestat (JNJ-54861911)
  • 2-Pyridinecarboxamide, N-[3-[(4S)-2-amino-4-methyl-4H-1,3-thiazin-4-yl]-4-fluorophenyl]-5-cyano-
  • (S)-N-(3-(2-Amino-4-methyl-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide
CAS:
1200493-78-2
MF:
C18H14FN5OS
MW:
367.4
Mol File:
1200493-78-2.mol
More
Less

Atabecestat Chemical Properties

Density 
1.39±0.1 g/cm3(Predicted)
pka
9.90±0.70(Predicted)
form 
Solid
color 
White to off-white
More
Less

Atabecestat Usage And Synthesis

Uses

Atabecestat (JNJ-54861911) is a potent brain-penetrant and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, achieves robust and high CSF Aβ reduction. Atabecestat s tolerated and displays a sustained pharmacokinetic (PK) and pharmacodynamic (PD) characteristics. Atabecestat has the potential for Alzheimer's Disease treatment[1].

in vivo

Atabecestat (100 and 300 mg/kg; p.o. once daily for 3 days) reduces the human Aβ levels in mice[2]. Atabecestat (300 mg/kg; p.o. once) inhibits the exacerbation of vascular abnormalities in APPPS1 mice with 3D6 treatment[2].

Animal Model:5-week-old APPPS1 mice[2]
Dosage:100 and 300 mg/kg
Administration:Oral gavage; 100 and 300 mg/kg; once daily for 3 days
Result:Reduced the level of human Aβ1-40 and Aβ1-42 levels in the brain of APPPS1 mice at a dose of 300 mg/kg and resulted in less reduction of human Aβ levels at 24 h with a dose of 100 mg/kg.

IC 50

BACE1

References

[1] Timmers M, et al. Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a?potent?oral BACE inhibitor.Alzheimers Dement (N Y).?2016 Aug 24;2(3):202-212. DOI:10.1016/j.trci.2016.08.001
[2] Janssens J, et al. Passive immunotherapy with a novel antibody against 3pE-modified Aβ demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice. Neurobiol Dis. 2021 Jul;154:105365. DOI:10.1016/j.nbd.2021.105365

AtabecestatSupplier

Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
Shanghai Rechem science Co., Ltd.
Tel
021-31433387 15618786686
Email
sales@rechemscience.com
Shanghai Biopharmaleader Co., Ltd.
Tel
+86 18721201413
Email
sales@biopharmaleader.com
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com